Evaluating the implementation of weekly rifapentine-isoniazid (3HP) for tuberculosis prevention among people living with HIV in Uganda: A qualitative evaluation of the 3HP Options Trial
View ORCID ProfileAllan Musinguzi, View ORCID ProfileJoan R. Kasidi, View ORCID ProfileJillian L. Kadota, Fred Welishe, Anne Nakitende, Lydia Akello, Jane Nakimuli, Lynn T. Kunihira, Bishop Opira, View ORCID ProfileYeonsoo Baik, View ORCID ProfileDevika Patel, View ORCID ProfileAmanda Sammann, Christopher A. Berger, View ORCID ProfileHélène E. Aschmann, View ORCID ProfilePayam Nahid, Robert Belknap, View ORCID ProfileMoses R. Kamya, View ORCID ProfileMargaret A. Handley, View ORCID ProfilePatrick PJ Phillips, View ORCID ProfileNoah Kiwanuka, Achilles Katamba, David W. Dowdy, View ORCID ProfileAdithya Cattamanchi, View ORCID ProfileFred C. Semitala, View ORCID ProfileAnne R. Katahoire
doi: https://doi.org/10.1101/2024.08.19.24308041
Allan Musinguzi
1Infectious Diseases Research Collaboration, Kampala, Uganda
Joan R. Kasidi
1Infectious Diseases Research Collaboration, Kampala, Uganda
Jillian L. Kadota
2Center for Tuberculosis and Division of Pulmonary and Critical Care Medicine, San Francisco General Hospital, University of California San Francisco, San Francisco, CA, USA
Fred Welishe
1Infectious Diseases Research Collaboration, Kampala, Uganda
Anne Nakitende
1Infectious Diseases Research Collaboration, Kampala, Uganda
Lydia Akello
1Infectious Diseases Research Collaboration, Kampala, Uganda
Jane Nakimuli
1Infectious Diseases Research Collaboration, Kampala, Uganda
Lynn T. Kunihira
3Uganda Tuberculosis Implementation Research Consortium, Walimu, Kampala, Uganda
Bishop Opira
1Infectious Diseases Research Collaboration, Kampala, Uganda
Yeonsoo Baik
4Department of International Health, Johns Hopkins Bloomberg School of Public Health, Baltimore, MD, USA
Devika Patel
5Department of Surgery, University of California San Francisco, San Francisco, CA, USA
6The Better Lab, University of California, San Francisco, CA, USA
Amanda Sammann
5Department of Surgery, University of California San Francisco, San Francisco, CA, USA
6The Better Lab, University of California, San Francisco, CA, USA
Christopher A. Berger
2Center for Tuberculosis and Division of Pulmonary and Critical Care Medicine, San Francisco General Hospital, University of California San Francisco, San Francisco, CA, USA
Hélène E. Aschmann
7Department of Epidemiology and Biostatistics and Division of Pulmonary and Critical Care Medicine, University of California San Francisco, San Francisco, CA, USA
Payam Nahid
2Center for Tuberculosis and Division of Pulmonary and Critical Care Medicine, San Francisco General Hospital, University of California San Francisco, San Francisco, CA, USA
Robert Belknap
8Denver Health and Hospital Authority and Division of Infectious Diseases, Department of Medicine, University of Colorado, Denver, CO, USA
Moses R. Kamya
1Infectious Diseases Research Collaboration, Kampala, Uganda
9Department of Medicine, School of Medicine, Makerere University College of Health Sciences, Kampala, Uganda
Margaret A. Handley
10Department of Epidemiology and Biostatistics, University of California San Francisco, San Francisco, CA, USA
Patrick PJ Phillips
2Center for Tuberculosis and Division of Pulmonary and Critical Care Medicine, San Francisco General Hospital, University of California San Francisco, San Francisco, CA, USA
Noah Kiwanuka
11Department of Epidemiology and Biostatistics, School of Public Health, Makerere University College of Health Sciences, Kampala, Uganda
Achilles Katamba
3Uganda Tuberculosis Implementation Research Consortium, Walimu, Kampala, Uganda
12Clinical Epidemiology & Biostatistics Unit, Department of Medicine, Makerere University College of Health Sciences, Kampala, Uganda
David W. Dowdy
3Uganda Tuberculosis Implementation Research Consortium, Walimu, Kampala, Uganda
13Department of Epidemiology, Johns Hopkins Bloomberg School of Public Health, Baltimore, MD, USA
Adithya Cattamanchi
2Center for Tuberculosis and Division of Pulmonary and Critical Care Medicine, San Francisco General Hospital, University of California San Francisco, San Francisco, CA, USA
3Uganda Tuberculosis Implementation Research Consortium, Walimu, Kampala, Uganda
14Division of Pulmonary Diseases and Critical Care Medicine, University of California Irvine, Irvine, CA, USA
Fred C. Semitala
1Infectious Diseases Research Collaboration, Kampala, Uganda
9Department of Medicine, School of Medicine, Makerere University College of Health Sciences, Kampala, Uganda
15Makerere University Joint AIDS Program, Kampala, Uganda
Anne R. Katahoire
16Child Health and Development Center, School of Medicine, Makerere University College of Health Sciences, Kampala, Uganda
Article usage
Posted August 22, 2024.
Evaluating the implementation of weekly rifapentine-isoniazid (3HP) for tuberculosis prevention among people living with HIV in Uganda: A qualitative evaluation of the 3HP Options Trial
Allan Musinguzi, Joan R. Kasidi, Jillian L. Kadota, Fred Welishe, Anne Nakitende, Lydia Akello, Jane Nakimuli, Lynn T. Kunihira, Bishop Opira, Yeonsoo Baik, Devika Patel, Amanda Sammann, Christopher A. Berger, Hélène E. Aschmann, Payam Nahid, Robert Belknap, Moses R. Kamya, Margaret A. Handley, Patrick PJ Phillips, Noah Kiwanuka, Achilles Katamba, David W. Dowdy, Adithya Cattamanchi, Fred C. Semitala, Anne R. Katahoire
medRxiv 2024.08.19.24308041; doi: https://doi.org/10.1101/2024.08.19.24308041
Evaluating the implementation of weekly rifapentine-isoniazid (3HP) for tuberculosis prevention among people living with HIV in Uganda: A qualitative evaluation of the 3HP Options Trial
Allan Musinguzi, Joan R. Kasidi, Jillian L. Kadota, Fred Welishe, Anne Nakitende, Lydia Akello, Jane Nakimuli, Lynn T. Kunihira, Bishop Opira, Yeonsoo Baik, Devika Patel, Amanda Sammann, Christopher A. Berger, Hélène E. Aschmann, Payam Nahid, Robert Belknap, Moses R. Kamya, Margaret A. Handley, Patrick PJ Phillips, Noah Kiwanuka, Achilles Katamba, David W. Dowdy, Adithya Cattamanchi, Fred C. Semitala, Anne R. Katahoire
medRxiv 2024.08.19.24308041; doi: https://doi.org/10.1101/2024.08.19.24308041
Subject Area
Subject Areas
- Addiction Medicine (349)
- Allergy and Immunology (668)
- Allergy and Immunology (668)
- Anesthesia (181)
- Cardiovascular Medicine (2648)
- Dermatology (223)
- Emergency Medicine (399)
- Epidemiology (12228)
- Forensic Medicine (10)
- Gastroenterology (759)
- Genetic and Genomic Medicine (4103)
- Geriatric Medicine (387)
- Health Economics (680)
- Health Informatics (2657)
- Health Policy (1005)
- Hematology (363)
- HIV/AIDS (851)
- Medical Education (399)
- Medical Ethics (109)
- Nephrology (436)
- Neurology (3882)
- Nursing (209)
- Nutrition (577)
- Oncology (2030)
- Ophthalmology (585)
- Orthopedics (240)
- Otolaryngology (306)
- Pain Medicine (250)
- Palliative Medicine (75)
- Pathology (473)
- Pediatrics (1115)
- Primary Care Research (452)
- Public and Global Health (6527)
- Radiology and Imaging (1403)
- Respiratory Medicine (871)
- Rheumatology (409)
- Sports Medicine (342)
- Surgery (448)
- Toxicology (53)
- Transplantation (185)
- Urology (165)